ArticleCurrent oncology (Toronto, Ont.)2024

Can Patient Characteristics and Pre-Treatment MRI Features Predict Survival After Stereotactic Ablative Radiotherapy (SABR) Treatment in Hepatocellular Carcinoma (HCC): Preliminary Assessment.

Rachel Gravell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.